ABCC1, ATP binding cassette subfamily C member 1, 4363
N. diseases: 333; N. variants: 28
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
16 | 16040137 | intron variant | T/C | snv | 0.30 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 15997650 | intron variant | C/T | snv | 2.0E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
16 | 16022699 | intron variant | G/T | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 16022699 | intron variant | G/T | snv | 0.45 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
16 | 16034059 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
16 | 16021035 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
16 | 16048222 | missense variant | G/T | snv | 8.9E-03 | 7.6E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.080 | 16 | 15961249 | intron variant | C/G | snv | 4.5E-03 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
16 | 16142666 | 3 prime UTR variant | T/G | snv | 0.95 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
16 | 16029602 | intron variant | A/C;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
1.000 | 0.080 | 16 | 16000744 | intron variant | A/G | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.080 | 16 | 16077249 | intron variant | A/G | snv | 0.13 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.080 | 16 | 16089188 | intron variant | G/A | snv | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | ||||||||||
|
1.000 | 0.080 | 16 | 16077291 | intron variant | G/A;T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||||
|
0.925 | 0.040 | 16 | 16102659 | missense variant | G/T | snv | 9.4E-06 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 16 | 16102659 | missense variant | G/T | snv | 9.4E-06 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.040 | 16 | 15995584 | intron variant | A/G | snv | 7.7E-02 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.925 | 0.040 | 16 | 15995584 | intron variant | A/G | snv | 7.7E-02 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.080 | 16 | 16090375 | intron variant | C/G | snv | 0.81 | 0.83 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.882 | 0.080 | 16 | 16090375 | intron variant | C/G | snv | 0.81 | 0.83 |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.882 | 0.080 | 16 | 16090375 | intron variant | C/G | snv | 0.81 | 0.83 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
1.000 | 0.040 | 16 | 16142147 | 3 prime UTR variant | T/A | snv | 0.36 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 16 | 16142147 | 3 prime UTR variant | T/A | snv | 0.36 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 16 | 16142147 | 3 prime UTR variant | T/A | snv | 0.36 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.827 | 0.120 | 16 | 16142793 | 3 prime UTR variant | T/A;C | snv |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |